Get Premium to unlock powerful stock data
BSP:T1EV34 (Israel)  
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

R$ 20.74 (-2.35%) Jun 29
P/E:
At Loss
P/B:
0.96
Market Cap:
R$ 23.03B ($ 4.39B)
Enterprise V:
R$ 158.27B ($ 30.18B)
Volume:
1.74K
Avg Vol (2M):
619.00
Also Trade In:
Volume:
1.74K
Market Cap R$:
23.03B
Market Cap $:
4.39B
PE Ratio:
At Loss
Avg Vol (2-Month):
619.00
Enterprise Value R$:
158.27B
Enterprise Value $:
30.18B
PB Ratio:
0.96
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Based in Israel, Teva is one of the world's largest generic drug manufacturers, with over 3,500 products marketed in over 60 countries. While a majority of its revenue is attributed to prescription generic drugs, Teva develops and markets its own branded specialty and biopharmaceutical products, primarily in the U.S. and in Europe. The company's branded portfolio generates one fifth of total revenue and consists of patented therapies targeting central nervous system conditions (Austedo, Ajovy, Copaxone), oncology (Bendeka/Treanda), and respiratory conditions (ProAir, Qvar). While global competition has facilitated the commodification of small-molecule generic drugs, Teva's portfolio rationalization has resulted in less overall price erosion versus peers.
Name Current Vs Industry Vs History
Cash-To-Debt 0.09
Equity-to-Asset 0.2
Debt-to-Equity 2.5
Debt-to-EBITDA 14.16
Interest Coverage 3.62
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.18
Distress
Grey
Safe
Beneish M-Score -2.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 55.35
9-Day RSI 53.77
14-Day RSI 51.59
6-1 Month Momentum % -10.66
12-1 Month Momentum % -15.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.07
Quick Ratio 0.73
Cash Ratio 0.19
Days Inventory 187.12
Days Sales Outstanding 102.71
Days Payable 73.83

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4

Financials (Next Earnings Date:2022-07-28 Est.)

BSP:T1EV34's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil R$) 81,579.319
EPS (TTM) (R$) -2.744
Beta 0
Volatility % 17.68
14-Day RSI 51.59
14-Day ATR (R$) 0.325287
20-Day SMA (R$) 20.636
12-1 Month Momentum % -15.94
52-Week Range (R$) 18.6 - 28.68
Shares Outstanding (Mil) 1,110.35

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Teva Pharmaceutical Industries Ltd Filings

Document Form Filing Date
No Filing Data